1-20 of 22
Authors: Sepideh Mokhtari
Journal Article
ANGI-07. A CASE OF HYPERBARIC OXYGEN USED AS A TREATMENT MODALITY FOR ANAPLASTIC ASTROCYTOMA Free
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii17, https://doi.org/10.1093/neuonc/noae165.0066
Published: 11 November 2024
Journal Article
NIMG-86. DISSEMINATEDCRYPTOCOCCUS NEOFORMANS MIMICKING CENTRAL NERVOUS SYSTEM PROGRESSION OF DIFFUSE LARGE B-CELL LYMPHOMA Free
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii215, https://doi.org/10.1093/neuonc/noae165.0850
Published: 11 November 2024
Journal Article
NCMP-28. CASE REPORT: REFRACTORY MYASTHENIA GRAVIS FLARE INDUCED BY IMMUNE CHECK POINT INHIBITOR Free
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii222–viii223, https://doi.org/10.1093/neuonc/noae165.0880
Published: 11 November 2024
Journal Article
SURG-26. HYDROCEPHALUS IN LEPTOMENINGEAL DISEASE: TANDEM OMMAYA RESERVOIR-SHUNT FOR INTRATHECAL CHEMOTHERAPY ADMINISTRATION Free
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v267, https://doi.org/10.1093/neuonc/noad179.1025
Published: 10 November 2023
Journal Article
INNV-37. BELZUTIFAN IMPACT ON VHL-ASSOCIATED CNS HEMANGIOBLASTOMAS Free
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v165, https://doi.org/10.1093/neuonc/noad179.0626
Published: 10 November 2023
Journal Article
CNSC-03. NEURONAL INTERMEDIATE FILAMENT (NIF) ANTIBODY POSITIVE PARANEOPLASTIC SYNDROME IN A PATIENT WITH METASTATIC NEUROENDOCRINE PANCREATIC CARCINOMA AND TREATMENT WITH IPILIMUMAB/NIVOLUMAB Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii22, https://doi.org/10.1093/neuonc/noac209.084
Published: 14 November 2022
Journal Article
NCMP-17. PLASMA EXCHANGE FOR IMMUNE CHECKPOINT INHIBITOR INDUCED ACUTE DEMYELINATING POLYNEUROPATHY REFRACTORY TO IVIG Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii194, https://doi.org/10.1093/neuonc/noac209.745
Published: 14 November 2022
Journal Article
CTIM-01. TITLE: PHASE 1B STUDY OF AVELUMAB AND WHOLE BRAIN RADIOTHERAPY (WBRT) IN PATIENTS WITH LEPTOMENINGEAL DISEASE (LMD): PRELIMINARY RESULTS Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii59, https://doi.org/10.1093/neuonc/noac209.233
Published: 14 November 2022
Journal Article
INNV-23. MANAGING CENTRAL NERVOUS SYSTEM MANIFESTATIONS OF CHRONIC GRAFT VERSUS HOST DISEASE FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION: A CASE REPORT Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii146, https://doi.org/10.1093/neuonc/noac209.563
Published: 14 November 2022
Journal Article
NCMP-23. A UNIQUE CASE OF CHOREIFORM DYSKINESIAS IN A PATIENT WITH METASTATIC RENAL CELL CARCINOMA Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii196, https://doi.org/10.1093/neuonc/noac209.751
Published: 14 November 2022
Journal Article
NCMP-16. UNIQUE PARANEOPLASTIC SYNDROME ASSOCIATED WITH CLL Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii194, https://doi.org/10.1093/neuonc/noac209.744
Published: 14 November 2022
Journal Article
Surgical and anatomic factors predict development of leptomeningeal disease in patients with melanoma brain metastases Free
Neuro-Oncology, Volume 24, Issue 8, August 2022, Pages 1307–1317, https://doi.org/10.1093/neuonc/noac023
Published: 29 January 2022
Journal Article
NCMP-08. CHALLENGING DIAGNOSIS AND MANAGEMENT OF PCNSL IN AN IMMUNOSUPPRESSED PATIENT ON MYCOPHENOLATE MOFETIL FOR MYASTHENIA GRAVIS Free
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Pages vi148–vi149, https://doi.org/10.1093/neuonc/noab196.581
Published: 12 November 2021
Journal Article
NCMP-21. IMMUNE-RELATED ACUTE MOTOR AXONAL NEUROPATHY: A SMALL CASE SERIES AND REVIEW OF THE LITERATURE Free
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi151, https://doi.org/10.1093/neuonc/noab196.592
Published: 12 November 2021
Journal Article
BIOM-02. LEPTOMENINGEAL DISEASE SECONDARY TO MELANOMA: UPDATES ON THE VALIDITY OF THE VERIDEX CELLSEARCH SYSTEM Free
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi10, https://doi.org/10.1093/neuonc/noab196.034
Published: 12 November 2021
Journal Article
Hypofractionated stereotactic re-irradiation with pembrolizumab and bevacizumab in patients with recurrent high-grade gliomas: results from a phase I study Free
Neuro-Oncology, Volume 23, Issue 4, April 2021, Pages 677–686, https://doi.org/10.1093/neuonc/noaa260
Published: 11 November 2020
Journal Article
NCMP-27. THE USE OF INTRAVENOUS IMMUNOGLOBULIN (IVIG) DURING SEVERE NEUROTOXICITY AMONG THE RECIPIENTS OF CHIMERIC ANTIGEN RECEPTOR T-CELLS (CAR-T) THERAPY Free
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii128, https://doi.org/10.1093/neuonc/noaa215.538
Published: 09 November 2020
Journal Article
NCMP-13. BRAIN MRI FINDINGS IN PATIENTS TREATED WITH CHIMERIC ANTIGEN RECEPTOR T-CELLS (CAR-T) DURING SEVERE NEUROTOXICITY Free
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Pages vi181–vi182, https://doi.org/10.1093/neuonc/noz175.759
Published: 11 November 2019
Journal Article
ATIM-17. A PHASE I TRIAL OF HYPOFRACTIONATED STEREOTACTIC IRRADIATION (HFSRT) COMBINED WITH NIVOLUMAB (NIVO), IPILIMUMAB (IPI) AND BEVACIZUMAB (BEV) IN PATIENTS (PTS) WITH RECURRENT HIGH GRADE GLIOMAS Free
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi5, https://doi.org/10.1093/neuonc/noz175.017
Published: 11 November 2019
Journal Article
NCMP-05. RITUXIMAB AS INITIAL THERAPY FOR THE REVERSAL OF MYASTHENIA GRAVIS NEUROTOXICITY CAUSED BY IPILIMUMAB/NIVOLUMAB Free
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi194, https://doi.org/10.1093/neuonc/noy148.806
Published: 05 November 2018
